Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
DLH Holdings Corp(DLHC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for DLHC
11/02/2026: DLHC (1-star) is currently NOT-A-BUY. Pass it for now.
DLH Holdings Corp is a focused provider of specialized healthcare and digital transformation services primarily for federal government agencies. Its main strength lies in its long-standing relationships with the Department of Veterans Affairs and Department of Health and Human Services. The company's growth story revolves around capturing larger, technology-driven contracts within these mission-critical federal sectors. Key risks include heavy revenue concentration within a few agencies and sensitivity to federal budget cycles and competitive bidding pressures. The stock may suit value-oriented investors who appreciate stable, government-backed revenue streams, though investors should monitor the company's ability to win new bids and integrate acquisitions efficiently.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Growth is tied to government budget cycles rather than high-velocity market expansion. |
| Momentum investor | Weak fit | The stock often lacks the sustained high volatility or rapid price appreciation sought by momentum strategies. |
| Value investor | Strong fit | The company is often priced based on steady, predictable government contract revenue streams. |
| Dividend investor | Weak fit | The company does not pay a dividend, favoring growth reinvestment. |
| Low-risk investor | Mixed fit | Government contracting provides revenue stability, but concentration risk in a few agencies exists. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | Contract award announcements and federal budget news can cause short-term stock price swings. |
| Valuation risk | Medium | Future growth expectations are tightly coupled with the ability to maintain win rates on federal bids. |
| Competition risk (GovCon Consolidation) | Medium / high | Larger prime contractors often compete aggressively for the same federal health budgets. |
| Business quality | Medium | Reliable recurring revenue from government clients provides a steady foundation. |
| Dividend income | Low / none | Investors should not expect income generation from this stock. |
| Execution risk | Medium | Successful integration of acquired entities and timely performance on complex government contracts is required. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -3.82% | Avg. Invested days 41 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/02/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 52.90M USD | Price to earnings Ratio - | 1Y Target Price 7 |
Price to earnings Ratio - | 1Y Target Price 7 | ||
Volume (30-day avg) 12.8K shares | Beta 1.42 | 52 Weeks Range 3.38 - 6.88 | Updated Date 11/02/2026 |
52 Weeks Range 3.38 - 6.88 | Updated Date 11/02/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.49 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Federal Health Services | Clinical operations, disability evaluations, and professional staffing for the VA and HHS. | The company acts as a specialized contractor helping government agencies run essential health programs. |
| Digital Transformation | IT services, data analytics, and cloud migration support for federal agency infrastructure. | The company helps modernize federal technology, which is a stable and recurring source of revenue. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE 17.45 | Enterprise Value 193.52M | Price to Sales(TTM) 0.21 |
Enterprise Value 193.52M | Price to Sales(TTM) 0.21 | ||
Enterprise Value to Revenue 0.76 | Enterprise Value to EBITDA 12.93 | Shares Outstanding 14.49M | Shares Floating 5.81M |
Shares Outstanding 14.49M | Shares Floating 5.81M | ||
Percent Insiders 15.14 | Percent Institutions 70.27 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.